Effect Of Salsaradi Gana Bhavit Haritakichurna In The Management Of Sthoola Pramehi( TYPE-2 Diabetes Mellitus)

A Clinical Study Of Salsaradi Gana Bhavit Haritaki Churna In The Management Of Sthoola Pramehi(TYPE-2 Diabetes Mellitus)-An Open Labelled Single Group Clinical Trail - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098778

Enrollment

Registered

2025-12-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications Health Condition 2: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Classical signs and symptoms of Prameha. Fasting plasma glucose 126- 200 mg/dl, Post Prandial glucose level 200- 300 mg/dl. Both insulin-dependent and non-insulin-dependent Type II Diabetes Mellitus patients will be included. Both newly diagnosed and patients on allopathic treatment with chronicity of 5 years will be included in this study. The dose of Modern Medicine will be adjusted and tapered during the period of trial as per need. Patients having BMI(Body Mass Index) greater than or equal to 25 will be taken for the study

Exclusion criteria

Exclusion criteria: Pre diagnose case of Chronic Pancreatitis, Ketoacidosis, and Parkinson s disease. Patients with other metabolic and endocrinal disorders. Patients have uncontrolled blood sugar. BMI less than 25 will be excluded. Fasting plasma glucose level greater than 200 mg/dl & Postprandial glucose level greater than 300 mg/dl will be excluded Patients having diagnosed with any other malignancies or any other systemic/ serious illness. Patients with diabetic wounds/ulcers Patients of Diabetes mellitus Type 1 (Juvenile Diabetes) Patients having acute & serious complications of Type 2 Diabetes Mellitus Patients Diagnosed with Coronary artery disease, Peripheral vascular disease & cerebrovascular disease Patients having a history of any major complications of Diabetes like Nephropathy, Retinopathy, Diabetic Foot, etc. Pregnant women. Otherwhere chronicles like STD, Tuberculosis, etc.

Design outcomes

Primary

Measure	Time frame
Improvement in laboratorial parameters as well as signs and symptoms of Sthoola Pramehi (Type II Diabetes Mellitus)Timepoint: 6 weeks	—

Secondary

Measure	Time frame
It is expected that the drug will break /eradicate the root cause of the disease leading to a prolong relief from symptoms of Diabetes in Sthoola Pramehi by its Rasayana PropertiesTimepoint: ;: It is expected that the drug will break /eradicate the root cause of the disease leading to a prolong relief from symptoms of Diabetes in Sthoola Pramehi by its Rasayana PropertiesTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Surendra A Soni

Goverment Akhandanand Ayurveda Collage and Hospital, Ahmedabad

surendraasoni@gmail.com09408441150

Outcome results